Your browser doesn't support javascript.
loading
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series.
Vento, Seija Inkeri; Vähämurto, Pauli; Silventoinen, Kaija; Karjalainen-Lindsberg, Marja-Liisa; Mannisto, Susanna; Leppä, Sirpa; Mäkitie, Antti Aarni.
Afiliación
  • Vento SI; a Department of Otorhinolaryngology - Head and Neck Surgery , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
  • Vähämurto P; a Department of Otorhinolaryngology - Head and Neck Surgery , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
  • Silventoinen K; b Department of Oncology and Research Program Unit, Medical Faculty , University of Helsinki and Helsinki University Hospital Cancer Center , Helsinki , Finland.
  • Karjalainen-Lindsberg ML; a Department of Otorhinolaryngology - Head and Neck Surgery , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
  • Mannisto S; c Department of Pathology , University of Helsinki and Helsinki University Hospital, Haartman Institute , Helsinki , Finland.
  • Leppä S; b Department of Oncology and Research Program Unit, Medical Faculty , University of Helsinki and Helsinki University Hospital Cancer Center , Helsinki , Finland.
  • Mäkitie AA; b Department of Oncology and Research Program Unit, Medical Faculty , University of Helsinki and Helsinki University Hospital Cancer Center , Helsinki , Finland.
Acta Otolaryngol ; 137(9): 975-980, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28537101
ABSTRACT

OBJECTIVES:

Extramedullary plasmacytoma in the sinonasal tract or nasopharynx is rare. The aim of the study was to review data on symptoms, clinical findings, treatment and follow-up of plasmacytomas in the sinonasal and nasopharyngeal regions in order to delineate the main clinical characteristics and the optimal management.

METHOD:

Twenty-five patients with sinonasal or nasopharyngeal plasmacytoma, diagnosed and treated at the Helsinki University Hospital during a 39-year period from 1975 to 2013 were retrospectively reviewed.

RESULTS:

There were 18 males and 7 females with a median age of 66 years (range, 36-80). Sixty-eight percent received only radiotherapy or (chemo)radiotherapy. Forty-seven percent of them had a complete response to primary radiotherapy and one patient had a complete response after receiving additional brachytherapy. Four patients were treated primarily with surgery only. Two of them had a local recurrence, but were then successfully treated with radiotherapy. Altogether, four patients received a combination of surgery and (chemo)radiotherapy. Forty-four percent were alive with no evidence of disease after a median follow-up time of 78 months. Forty percent died of their disease and 16% died of other causes.

CONCLUSIONS:

Our study supports radiotherapy as a treatment of choice, but for small tumours surgery alone or in combination with radiotherapy may also be considered.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmacitoma / Neoplasias de los Senos Paranasales / Neoplasias Nasofaríngeas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Acta Otolaryngol Año: 2017 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmacitoma / Neoplasias de los Senos Paranasales / Neoplasias Nasofaríngeas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Acta Otolaryngol Año: 2017 Tipo del documento: Article País de afiliación: Finlandia
...